Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD4 | P21917 | 9/20 | 0.45 |
| ▸ | DRD2 | P14416 | 2/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6950204 | 0.93 | SLC6A4 (0.44) | DRD4SLC6A4KDM4EALDH1A1HTT | |
| Fumaric Acid SCHEMBL8671240 | 0.93 | SMN1; SMN2 (0.46) | DRD4DRD2KDM4EALDH1A1HTT | |
| Fumaric Acid SCHEMBL8671237 | 0.93 | SMN1; SMN2 (0.46) | DRD4DRD2KDM4EALDH1A1HTT | |
| Hydrochloric Acid SCHEMBL8670829 | 0.92 | SLC6A4 (0.43) | DRD4SLC6A4KDM4EALDH1A1HTT | |
| SCHEMBL6947216 | 0.89 | SLC6A4 (0.55) | DRD4DRD2SLC6A4SMN1; SMN2 | |
| SCHEMBL6946044 | 0.88 | SLC6A4 (0.43) | DRD4SLC6A4KDM4EALDH1A1HTT | |
| Fumaric Acid SCHEMBL8669282 | 0.83 | SMN1; SMN2 (0.48) | SLC6A4KDM4EALDH1A1HTTSMN1; SMN2 | |
| Fumaric Acid SCHEMBL8669278 | 0.83 | SMN1; SMN2 (0.48) | SLC6A4KDM4EALDH1A1HTTSMN1; SMN2 | |
| SCHEMBL6953959 | 0.82 | SLC6A4 (0.58) | DRD4DRD2SLC6A4KDM4EALDH1A1 | |
| Hydrochloric Acid SCHEMBL6952909 | 0.81 | SLC6A4 (0.57) | DRD4DRD2SLC6A4KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0709378-B1 | Aminoalkyloximes, a process for their preparation, their use as medicaments and intermediate compounds | AVENTIS PHARMA INC (US) | 2003-03-19 | — | — | EP | claimed |
| US-5696142-A | TREATING DEPRESSION, OBSESSIVE COMPULSIVE DISORDERS | HOECHST MARION ROUSSEL, INC. (US) | 1997-12-09 | — | — | US | claimed |
| EP-0709378-A2 | Aminoalkyloximes, a process for their preparation, their use as medicaments and intermediate compounds | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1996-05-01 | — | — | EP | claimed |